Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Transplant Recipients
Open Access
- 26 October 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (17), 1111-1116
- https://doi.org/10.1056/nejm199510263331704
Abstract
An aggressive and potentially fatal form of coronary artery disease may develop after cardiac transplantation. We studied the role of vascular tissue plasminogen activator (t-PA), the primary mediator of fibrinolysis, in the development of this problem.Keywords
This publication has 23 references indexed in Scilit:
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- THE RELATIONSHIP AMONG DONOR-RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1Transplantation, 1994
- TISSUE PLASMINOGEN ACTIVATOR IN HUMAN CARDIAC ALLOGRAFTSTransplantation, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- INDUCTION OF VASCULAR ADHESION MOLECULES DURING REJECTION OF HUMAN CARDIAC ALLOGRAFTSTransplantation, 1992
- Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferationJournal of the American College of Cardiology, 1990
- Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findingsJournal of the American College of Cardiology, 1988
- Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.Journal of Clinical Pathology, 1985
- Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.The Journal of Experimental Medicine, 1984